![Lena Birgitta Degling Wikingsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lena Birgitta Degling Wikingsson
Directeur Général chez
Dilafor AB
Profil
Lena Birgitta Degling Wikingsson is currently Chief Executive Officer at Dilafor AB since 2011, Chairman at Simplexia AB since 2010, and Director at both XNK Therapeutics AB and Dilafor Incentive AB. Former roles include Chief Executive Officer at Avaris AB from 2010 to 2011, Non-Executive Director at Eurocine Vaccines AB from 2012 to 2016, President at Independent Pharmaceutica AB from 2002 to 2010, Chairman at NextCell Pharma AB, Independent Director at Biosergen AB and Alzinova AB, Principal at Active Biotech AB, SBL Vaccin AB, Accuro Immunology AB, and Medical Products Group, Inc. Education includes graduate and doctorate degrees from the University of Uppsala.
Postes actifs de Lena Birgitta Degling Wikingsson
| Sociétés | Poste | Début |
|---|---|---|
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Directeur Général | 18/05/2011 |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Directeur/Membre du Conseil | - |
Dilafor Incentive AB | Directeur/Membre du Conseil | - |
Simplexia AB
 Simplexia AB BiotechnologyHealth Technology Provides biotechnological research and development services | Président | 01/01/2010 |
Anciens postes connus de Lena Birgitta Degling Wikingsson
| Sociétés | Poste | Fin |
|---|---|---|
| EUROCINE VACCINES AB | Directeur/Membre du Conseil | 01/01/2016 |
Avaris AB
 Avaris AB Miscellaneous Commercial ServicesCommercial Services Provides cancer therapies based on gen- and cell-therapy | Directeur Général | 01/12/2011 |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction. | President | 01/01/2010 |
| BIOSERGEN AB | Directeur/Membre du Conseil | - |
| NEXTCELL PHARMA AB | Président | - |
Formation de Lena Birgitta Degling Wikingsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Eurocine Vaccines AB
 Eurocine Vaccines AB Pharmaceuticals: MajorHealth Technology Develops nasal influenza vaccines | Health Technology |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology Develops and produces vaccines | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Develops and manufactures active immunotherapy products | Health Technology |
Independent Pharmaceutica AB
Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction. | Distribution Services |
Medical Products Group, Inc.
 Medical Products Group, Inc. Medical DistributorsDistribution Services Provides medical equipment and services | Distribution Services |
Avaris AB
Avaris AB Miscellaneous Commercial ServicesCommercial Services Provides cancer therapies based on gen- and cell-therapy | Commercial Services |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Health Technology |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
NextCell Pharma AB
 NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
Simplexia AB
Simplexia AB BiotechnologyHealth Technology Provides biotechnological research and development services | Health Technology |
Dilafor Incentive AB | |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
